dPCR and qPCR Market Trends and Size by 2030
The dPCR and qPCR market size is projected to reach US$ 18,230.74 million by 2030 from US$ 8,976.99 million in 2022. The market is expected to register a CAGR of 9.30% during 2022–2030. The development of droplet digital PCR will likely remain a key trend in the market.
dPCR and qPCR Market Analysis
Nucleic acid quantification in molecular biology is facilitated by two essential technologies: quantitative PCR (qPCR) and digital PCR (dPCR). The market is expected to grow due to ongoing innovations that improve PCR technologies' accuracy, efficiency, and affordability and the integration of AI and machine learning for improved data analysis and interpretation. The leading companies in the market are Agilent Technologies Inc., QIAGEN N.V., Roche Diagnostics, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. The demand for dPCR and qPCR is expected to grow significantly due to rising disease prevalence, technological advancements, and increased research and development. Nevertheless, despite obstacles like exorbitant expenses and technological constraints, the market offers profitable prospects for advancement and growth, especially in developing nations.
dPCR and qPCR Market Overview
In the domains of recombinant DNA technology, which encompasses recombinant protein synthesis and PCR technology for amplification and quantification goals, gene synthesis is the most widely recognized instrument. In 2021, Mercia led a US$10 million Series A funding round for Camena Bioscience, a synthetic biology startup that supplies genes to the biotechnology and pharmaceutical industries. With the extra cash, the business will grow and continue to develop its revolutionary DNA synthesis platform, gSynth. The technology platform and other relevant resources accelerate the company's development of gene synthesis. Additionally, businesses have expanded the funds allocated to research and development to improve gene synthesis. The completion of its Series B funding round was announced in 2020 by EVONETIX LTD, a synthetic biology startup developing a desktop platform for high-fidelity, quick, and scalable gene synthesis. In this round, the business raised US$ 30 million (£23 million) under the direction of new investor Foresite Capital. Along with Rising Tide Fund and Civilization Ventures, other investors who took part in the round included Draper Esprit, DCVC (Data Collective), the Morningside group, Providence Investment Company, and Cambridge Consultants Ltd. Thus, growing government company investments support the expansion of the global gene synthesis market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
dPCR and qPCR Market: Strategic Insights
Market Size Value in US$ 8,976.99 million in 2022 Market Size Value by US$ 18,230.74 million by 2030 Growth rate CAGR of 9.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
dPCR and qPCR Market: Strategic Insights
| Market Size Value in | US$ 8,976.99 million in 2022 |
| Market Size Value by | US$ 18,230.74 million by 2030 |
| Growth rate | CAGR of 9.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
dPCR and qPCR Market Drivers and Opportunities
Technological Advancements in PCR Technologies Favor Market Growth
In most molecular biology labs, the polymerase chain reaction (PCR) is a robust, nearly universal technology used to amplify specific DNA stretches for genotyping, cloning, and analyzing single nucleotide variations. It is also the foundation for most next-generation sequencing (NGS) preparations. Technological advancements are producing different kinds of PCR techniques. Currently, PCR technology is being investigated for several unconventional uses, which will facilitate and expedite molecular diagnosis. Specifically, digital and real-time PCR improvements are utilized to support forensic investigations, identify viruses and bacteria, and diagnose illnesses.
Additionally, the researchers are attempting to use some nanomaterials to shorten test times. Announcing the development of ultrafast PCR technology in March 2023 was the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon). The research team led by Dr. Sang Kyung Kim and Dr. Seungwon Jung made this announcement. Using photothermal nanomaterials, the ultrafast PCR cuts the test duration in half compared to the previous test. The new method takes five minutes to complete and has diagnostic performance comparable to the current test method. Therefore, the growth of the dPCR and qPCR markets is driven by technological advancements in PCR technologies.
Rising Adoption of PCR Methods in Emerging Countries Creates Significant Opportunities in the Market
Molecular techniques like PCR have advanced as diagnostic tools in recent years. The technique is regarded as an essential research and diagnostic tool because it allows medical professionals to accurately diagnose a wide range of infectious diseases. With PCR, a single DNA strand can produce millions of copies of itself. It also makes early disease diagnosis possible, which makes it crucial for disease control. It is widely accepted because PCR produces consistent results that can be compared across labs. PCR methods are becoming more popular in developing nations. The World Health Organization is offering the required technical assistance to establish PCR laboratories in each of the 11 WHO South East Asia member states, according to the World Health Organization Report on Establishment of PCR Laboratory in Developing Countries (2016). The labs will support the delivery of top-notch healthcare. Depending on their needs, these PCR labs have embraced various PCR technologies, including digital PCR (dPCR), multiplex PCR, real-time PCR, in-situ PCR, and reverse transcriptase PCR (RT-PCR). As a result of its ease of use, speed, and high specificity in disease screening, as well as its growing applications in clinical microbiology, virology, parasitology, biotechnology, and related fields, the dPCR and qPCR market in developing nations is anticipated to grow significantly over the following years.
dPCR and qPCR Market Report Segmentation Analysis
Key segments that contributed to the derivation of the dPCR and qPCR market analysis are treatment, product, application, and end user.
- Based on treatment, the dPCR and qPCR market is segmented into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held the most significant market share in 2022.
- By product, the market is categorized into instruments, software & services, and reagents & consumables. The reagents & consumables segment held the largest share of the market in 2022.
- Based on application, the dPCR and qPCR market is segmented into research applications, clinical applications, and forensic applications. The clinical application segment held the most significant market share in 2022.
- By end user, the market is segmented into pharmaceutical and biotechnology companies, hospitals and diagnostic centers, forensic laboratories, research laboratories and academic institutes, and clinical research organizations. The hospitals and diagnostic centers segment held a significant market share in 2022.
dPCR and qPCR Market Share Analysis by Geography
The geographic scope of the dPCR and qPCR market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The US, Canada, and Mexico comprise the North American dPCR and qPCR market segments. The US and Canada have the most significant market shares in North America, the region's primary biotechnology market. The presence of key market players, a rise in demand for innovative products from bio-analytical instrument manufacturers and PCR companies, and extensive research and development across multiple academic and research institutes all contribute to the market growth in North America. The growing emphasis on using advanced techniques in healthcare, public and private efforts to advance precision medicine, and significant funding for genomic research from public and private sources are all anticipated to spur growth and significantly increase revenue generation for North America's dPCR and qPCR markets. Furthermore, the nation's research groups have made scientific advancements that align with the region's growth and dominance in the global market positioning.
dPCR and qPCR Market Report Scope
dPCR and qPCR Market News and Recent Developments
The dPCR and qPCR market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the dPCR and qPCR market are listed below:
- QIAGEN NV announced the expansion of its digital PCR (dPCR) offering to develop cell and gene therapies in the biopharma industry. The company has partnered with Niba Labs to offer customized digital PCR assay design services to biopharma customers and also launched the new CGT Viral Vector Lysis Kit that enables a standardized workflow from cell lysates to absolute and precise quantification of viral titers for multiple serotypes. (Source: QIAGEN NV, Press Release, July 2023)
- Roche and its subsidiary TIB Molbiol have developed three unique LightMix Modular Virus kits in response to recent monkeypox virus concerns. Multiple clusters of the monkeypox virus have been reported within the past two weeks in several European countries and North America, regions where the virus is not commonly found. (Source: Roche, Press Release, May 2023)
dPCR and qPCR Market Report Coverage and Deliverables
The “dPCR and qPCR Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- dPCR and qPCR market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- dPCR and qPCR market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- dPCR and qPCR market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the dPCR and qPCR market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment, Product, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The development of droplet digital PCR will likely remain a key trend in the market.
Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen NV, Standard Biotools Inc., Takara Bio Inc., Lepu Medical Technology, F. Hoffmann-la Roche Ltd, Bio-rad Laboratories Inc, Beijing Co Ltd, Agilent Technologies Inc.
The market is expected to register a CAGR of 9.30% during 2022–2030.
North America dominated the dPCR and qPCR market in 2022
Key factors driving the market are the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. dPCR and qPCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. dPCR and qPCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market - Global Market Analysis
6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020–2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. dPCR and qPCR Market - Geographical Analysis
11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.4 North America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.5 North America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6 North America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.1 North America dPCR and qPCR Market, by Country
11.1.6.2 US
11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.3 Canada
11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.4 Mexico
11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.4 Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.5 Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.1 Europe dPCR and qPCR Market, by Country
11.2.6.2 UK
11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.3 Germany
11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.4 France
11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.5 Italy
11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.6 Spain
11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.7 Rest of Europe
11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
11.3.6.2 China
11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.3 Japan
11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.4 India
11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.5 Australia
11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.6 South Korea
11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.7 Rest of Asia Pacific
11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.3 UAE
11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.4 South Africa
11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.1 South & Central America dPCR and qPCR Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.3 Argentina
11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
12. dPCR and qPCR Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bio-Rad Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Genome Diagnostics Pvt Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 SWOT Analysis
13.10.5 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. dPCR and qPCR Market Segmentation
Table 2. dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. US dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. US dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. US dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. US dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. US dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 24. Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 25. Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 28. UK dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 29. UK dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. UK dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. UK dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 32. UK dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 33. Germany dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 38. France dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 39. France dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 40. France dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 41. France dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 42. France dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 43. Italy dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 44. Italy dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 48. Spain dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 49. Spain dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 50. Spain dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 51. Spain dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 52. Spain dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Europe dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Europe dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Europe dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 56. Rest of Europe dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 57. Rest of Europe dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 59. Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 60. Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 62. Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 63. China dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 64. China dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 65. China dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 66. China dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. China dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Japan dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 69. Japan dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 70. Japan dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. Japan dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 72. Japan dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 73. India dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 74. India dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. India dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 76. India dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 77. India dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 78. Australia dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 79. Australia dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 80. Australia dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 81. Australia dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 82. Australia dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 83. South Korea dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 84. South Korea dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 85. South Korea dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 86. South Korea dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 87. South Korea dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 88. Rest of Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 93. Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 94. Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 95. Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 96. Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 98. Saudi Arabia dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 99. Saudi Arabia dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 100. Saudi Arabia dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 101. Saudi Arabia dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 102. Saudi Arabia dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 103. UAE dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 104. UAE dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. UAE dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 106. UAE dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 107. UAE dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 108. South Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 109. South Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 110. South Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 111. South Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 112. South Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 113. Rest of Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 114. Rest of Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 115. Rest of Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 116. Rest of Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 117. Rest of Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 118. South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 119. South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 120. South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 121. South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 122. South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 123. Brazil dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 124. Brazil dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 125. Brazil dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 126. Brazil dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 127. Brazil dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 128. Argentina dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 129. Argentina dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 130. Argentina dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 131. Argentina dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 132. Argentina dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 133. Rest of South & Central America dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of South & Central America dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of South & Central America dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of South & Central America dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of South & Central America dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 138. Recent Organic Growth Strategies in dPCR and qPCR Market
Table 139. Recent Inorganic Growth Strategies in the dPCR and qPCR Market
Table 140. Glossary of Terms, dPCR and qPCR Market
List of Figures
Figure 1. dPCR and qPCR Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. dPCR and qPCR Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 6. dPCR and qPCR Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 8. Quantitative PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Digital PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 11. Reagents & Consumables: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Instruments: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Software & Services: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 15. Research Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Clinical Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Forensic Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 19. Hospitals and Diagnostic Centers: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories and Academic Institutes: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Forensic Laboratories: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Clinical Research Organizations: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: dPCR and qPCR Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Europe dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 31. Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 33. UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Asia Pacific dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 40. Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 42. China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Middle East & Africa dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 49. Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 51. Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. South & Central America dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 56. South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 58. Brazil dCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Growth Strategies in dPCR and qPCR Market
The List of Companies - dPCR and qPCR Market
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Qiagen NV
- Standard Biotools Inc.
- Lepu Medical Technology Beijing Co Ltd
- F. Hoffmann-la Roche Ltd
- Bio-rad Laboratories Inc
- Agilent Technologies Inc
- Genome Diagnostics Pvt Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For